Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from China Resources Pharmaceutical Group Ltd. ( (HK:3320) ) is now available.
China Resources Pharmaceutical Group Ltd. announced an interim dividend of RMB 0.072 per share for the six months ending June 30, 2025, with the option for shareholders to receive the dividend in Hong Kong dollars at an exchange rate of RMB 1 to HKD 1.0957. This announcement reflects the company’s stable financial performance and commitment to delivering shareholder value, potentially enhancing its market position and investor confidence.
The most recent analyst rating on (HK:3320) stock is a Buy with a HK$7.50 price target. To see the full list of analyst forecasts on China Resources Pharmaceutical Group Ltd. stock, see the HK:3320 Stock Forecast page.
More about China Resources Pharmaceutical Group Ltd.
China Resources Pharmaceutical Group Ltd. operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products and services. The company is a significant player in the market, providing a wide range of healthcare solutions.
Average Trading Volume: 12,295,656
Technical Sentiment Signal: Sell
Current Market Cap: HK$32.23B
See more data about 3320 stock on TipRanks’ Stock Analysis page.